Stock listing

Syncom Formulation (india) Ltd.

Selected listing: SYNCOMF · BSE · INR · IN

Syncom Formulation (india) Ltd. (BSE:SYNCOMF), Health Technology. Latest release Aug 8, 2025: Syncom Formulations (India) Says Rahul Vijay Bankda Appointed…

SYNCOMF:BSEINRINUpdated October 2, 2026
Syncom Formulation (india) Ltd. logo
Ticker
BSE:SYNCOMF
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BSE
Currency
INR

About Syncom Formulation (india) Ltd.

Syncom Formulation (India) Ltd. is a public company listed under the ticker SYNCOMF in the Indian market. Syncom specializes in the formulation of pharmaceutical products, contributing to the healthcare sector in India.

Latest news from Syncom Formulation (india) Ltd.

Syncom Formulations (India) Says Rahul Vijay Bankda Appointed As CFO Effective August 9

August 8, 2025

Small-cap stunners today: Five small-cap stocks that clocked 10% gains today

September 9, 2024

All Syncom Formulation (india) Ltd. news →

Research Syncom Formulation (india) Ltd.

Syncom Formulation (india) Ltd. company profile

View the public company page for Syncom Formulation (india) Ltd. on 6ix.

Syncom Formulation (india) Ltd. news

Read company news and market updates connected to Syncom Formulation (india) Ltd..

Syncom Formulation (india) Ltd. investor events

Find investor webinars, events, and replay context for Syncom Formulation (india) Ltd..

Alternate listings

SYNCOMF:NSE

IN · INR

Alternate listing for Syncom Formulation (india) Ltd.; the primary context on this page is SYNCOMF:BSE.